← Open Payments lookup

KELLY WILSON: Open Payments

NPI 1124318027 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,288 in 65 payments from 14 companies in 2025. Trend: 2023 $1,105 · 2024 $1,177 · 2025 $1,288

Food & beverage: $1,247Education: $41
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.14$281
GlaxoSmithKline, LLC.20$209
Amgen Inc.10$167
Ionis Pharmaceuticals, Inc.3$155
Boehringer Ingelheim Pharmaceuticals, Inc.1$98
Novartis Pharmaceuticals Corporation4$90
GENZYME CORPORATION2$52
ARS Pharmaceuticals Operations, Inc.2$49
CSL Behring2$46
Galderma Laboratories, L.P.2$43

Products named: DUPIXENT, TEZSPIRE, DAWNZERA, TRELEGY ELLIPTA, NUCALA, OFEV, NEFFY, Rhapsido.

Industry payments across CA — which companies pay providers there.